Completed
Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.
NCT00468689
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States